| Download ( PDF | 757kB) |
Pharmakokinetik von Cefixim bei Probanden und ein Literaturvergleich mit neuen Ester Prodrug Cephalosporinen [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins]
Kees, Frieder K. und Naber, K. G. (1990) Pharmakokinetik von Cefixim bei Probanden und ein Literaturvergleich mit neuen Ester Prodrug Cephalosporinen [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins]. Infection 18 Suppl 3, S150-S154.Veröffentlichungsdatum dieses Volltextes: 30 Nov 2012 07:21
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.26835
Zusammenfassung
The pharmacokinetic parameters of cefixime were determined in healthy volunteers following oral administration of 200 mg cefixime as tablet, syrup and dry suspension, respectively. All three galenic formulations showed reliable absorption. Mean peak plasma concentrations amounted to 2.4-3.4 mg/l and were reached after 3.3-3.5 h. Mean terminal half-lives were 2.9-3.1 h. The mean areas under the ...
The pharmacokinetic parameters of cefixime were determined in healthy volunteers following oral administration of 200 mg cefixime as tablet, syrup and dry suspension, respectively. All three galenic formulations showed reliable absorption. Mean peak plasma concentrations amounted to 2.4-3.4 mg/l and were reached after 3.3-3.5 h. Mean terminal half-lives were 2.9-3.1 h. The mean areas under the plasma concentration-time curves ranged between 18 and 26 mg/l.h; 18-24% of the dose administered were recovered unchanged in the urine. The best bioavailability was obtained with the dry suspension followed by the tablet and the syrup. With respect to the ester pro-drug cephalosporins, cefuroxime axetil, cefetamet pivoxyl and cefotiam hexetil, cefixime exhibits higher plasma half-life and area under the curve as well as, comparable absolute bioavailability but consistently lower urinary recovery which indicates higher non-renal clearance.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||||||||||||||||||||||||||||||||||
| Titel eines Journals oder einer Zeitschrift | Infection | ||||||||||||||||||||||||||||||||||||
| Verlag: | MMV Medizin Verlag/Springer | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Band: | 18 Suppl 3 | ||||||||||||||||||||||||||||||||||||
| Seitenbereich: | S150-S154 | ||||||||||||||||||||||||||||||||||||
| Datum | 1990 | ||||||||||||||||||||||||||||||||||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmakologie und Toxikologie (Prof. Schlossmann, ehemals Prof. Seifert) | ||||||||||||||||||||||||||||||||||||
| Identifikationsnummer |
| ||||||||||||||||||||||||||||||||||||
| Klassifikation |
| ||||||||||||||||||||||||||||||||||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||||||||||||||||||||||||||||||||||
| Status | Veröffentlicht | ||||||||||||||||||||||||||||||||||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||||||||||||||||||||||||||||||||||
| An der Universität Regensburg entstanden | Unbekannt / Keine Angabe | ||||||||||||||||||||||||||||||||||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-268356 | ||||||||||||||||||||||||||||||||||||
| Dokumenten-ID | 26835 |
Downloadstatistik
Downloadstatistik